Back to Search
Start Over
Bristol-Myers Squibb and Pfizer reported negative preliminary results from a phase III trial of apixaban for the prevention of venous thromboembolism (VTE)
- Source :
- CenterWatch Weekly. September 2, 2008, Vol. 12 Issue 35, p7, 1 p.
- Publication Year :
- 2008
-
Abstract
- Bristol-Myers Squibb and Pfizer reported negative preliminary results from a phase III trial of apixaban for the prevention of venous thromboembolism (VTE). This study, dubbed ADVANCE-1, enrolled 3,000 subjects undergoing [...]
Details
- Language :
- English
- ISSN :
- 15285731
- Volume :
- 12
- Issue :
- 35
- Database :
- Gale General OneFile
- Journal :
- CenterWatch Weekly
- Publication Type :
- News
- Accession number :
- edsgcl.188643754